Literature DB >> 10978505

Transcription by RNA polymerase II in DNA-PK deficient scid mouse cells.

H M Sheppard1, X Liu.   

Abstract

DNA-dependent protein kinase (DNA-PK) is involved in DNA repair but there is some evidence to suggest that it is also involved in regulating transcription. We used a pair of cell lines, SCVA2 and SC(8)-10, which are DNA-PK negative and positive respectively, in order to examine the effect of DNA-PK upon transcription. Initial experiments were performed using p53 as an activator of transcription because DNA-PK has been proposed as a candidate upstream activator of p53. It was found both in vivo and in vitro that efficient p53-dependent transcription required the presence of DNA-PK. However, phosphorylation of p53 by DNA-PK did not affect the DNA-binding ability of p53 nor its transcriptional activity when tested in vitro. Subsequent in vivo experiments suggested that a number of transcription activators functioned more efficiently in the presence of DNA-PK. Therefore DNA-PK may play a general role in regulation of transcription driven by RNA polymerase II. In addition, DNA-PK is shown to have no specific effect on p53-dependent transcription.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10978505     DOI: 10.1016/s0167-4781(00)00155-x

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  2 in total

1.  Comprehensive proteomic analysis of influenza virus polymerase complex reveals a novel association with mitochondrial proteins and RNA polymerase accessory factors.

Authors:  Birgit G Bradel-Tretheway; Jonelle L Mattiacio; Alexei Krasnoselsky; Catherine Stevenson; David Purdy; Stephen Dewhurst; Michael G Katze
Journal:  J Virol       Date:  2011-06-29       Impact factor: 5.103

2.  Enhancement of recombinant adeno-associated virus type 2-mediated transgene expression in a lung epithelial cell line by inhibition of the epidermal growth factor receptor.

Authors:  Andrew D Smith; Roy F Collaco; James P Trempe
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.